{"nct_id":"NCT00443053","title":"Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2007-03","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2009-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}